US 11033554
Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration
granted A61KA61K31/40A61K31/4439
Quick answer
US patent 11033554 (Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/40, A61K31/4439, A61K31/444, A61K31/445